Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases

NCT07100600 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

224

Enrollment

OTHER_GOV

Sponsor class

Conditions

HER2-positive Advanced Breast Cancer
Brain Metastases
Radiotherapy

Interventions

DRUG: Trastuzumab Rezetecan
RADIATION: FSRT or WBRT

Sponsor

Henan Cancer Hospital